Neovasc Inc. - Common Shares (NQ:NVCN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 10, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Neovasc Inc. - Common Shares

< Previous 1 2 Next >

A Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and Hold ↗

February 22, 2023

This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023 ↗

January 18, 2023

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Neovasc: Q4 Earnings Insights ↗

March 10, 2022

Neovasc (NASDAQ:NVCN) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Neovasc beat...

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

Why Are Neovasc Shares Moving Higher On Thursday? ↗

September 16, 2021

The

Via Benzinga

Nasdaq Edges Higher; Neovasc Shares Jump ↗

January 17, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.

Via Benzinga

Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 17, 2023

Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...

Via Benzinga

Why Neovasc Shares Are Trading Higher Today ↗

January 17, 2023

Neovasc Inc. (NASDAQ: NVCN) shares are trading higher after ShockWave Medical, Inc. (NASDAQ: SWAV) announced it would acquire the company.

Via Benzinga

Earnings Scheduled For August 10, 2021 ↗

August 10, 2021

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Dow Dinged As Big Bank Earnings Weigh ↗

January 17, 2023

A round of earnings from the banking sector is weighing today, stifling Wall Street's early 2023 momentum.

Via Talk Markets

Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views ↗

January 17, 2023

U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.

Via Benzinga

Dow Drops Over 150 Points; Goldman Sachs Profit Misses Expectations ↗

January 17, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Tuesday.

Via Benzinga

Shockwave Medical Seeks To Bolster Its Cardiovascular Disease Portfolio With Neovasc Acquisition ↗

January 17, 2023

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

May 02, 2022

Monday's session saw 22 companies set new 52-week highs.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

November 25, 2022

On Friday, 68 companies reached new 52-week highs.

Via Benzinga

Neovasc Receives FDA Approval for COSIRA-II Clinical Trial ↗

October 19, 2021

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Neovasc Inc. (...

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

74 Biggest Movers From Yesterday ↗

April 29, 2022

Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric...

Via Benzinga

Real World Study Shows Neovasc's Reducer Is Safe, Efficacious In Patients With Refractory Angina ↗

June 18, 2021

Neovasc Inc (NASDAQ: NVCN) has announced the publication of an article highlighting the long-term outcomes of patients suffering from refractory angina treated...

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

June 02, 2021

Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

22 Stocks Moving in Wednesday's Pre-Market Session ↗

June 02, 2021

Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) rose 37.2% to $1.99 in pre-market trading after the company said it received orphan drug designation from the European...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

66 Biggest Movers From Yesterday ↗

June 03, 2021

Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped...

Via Benzinga

The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing ↗

May 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.